Tech Company M&A Transactions
Prosetta Biosciences Acquisition
Prosetta Biosciences, operating out of San Francisco, was acquired by VCampus. VCampus said the transaction price was $2.1 million.
Transaction Overview
Company Name
Acquired By
Announced On
6/13/2006
Transaction Type
M&A
Amount
$2,100,000
M&A Terms
The $2.1 million purchase price was paid with approximately $1.4 million in cash and the balance in certain assumed liabilities and notes payable. VCampus acquired all of the newly issued capital stock of Prosoft at closing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
670 5th St.
San Francisco, CA 94107
USA
San Francisco, CA 94107
USA
Phone
Website
Email Address
Overview
Prosetta Biosciences, Inc. is a biotechnology company developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS) by scientists at the University of California, San Francisco and the University of Washington, Seattle.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vishwanath Lingappa
VP - Bus. Development
Jeffrey Swarz
Browse more venture capital transactions:
Prev: 6/13/2006: BridgeCo venture capital transaction
Next: 6/13/2006: Oddcast venture capital transaction
Share this article
Where The Data Comes From
We record tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs